Citations

Clear

3485 citation(s) found for "Sy, Sarah".

Laparoscopic access to the liver and application of laparoscopic microwave ablation in 2 dogs with liver neoplasia
Oramas, Alberto, Case, J. Brad , Toskich, Beau , Fox‐Alvarez, W. Alexander, Boston, Sarah E., Giglio, Robson F., Dark, Michael J. , Toskich, Beau B. , Giglio, Robson F.

Mayo Clinic

Veterinary Surgery | January 22, 2019 | Volume: 48 | Issue: S1 | Pages: No page available

10.1111/vsu.13153 | PMID 30666685 Get It

AbstractObjectiveTo determine laparoscopic accessibility of liver lobes and access to the hilus and describe laparoscopic microwave ablation (LMWA) in 2 dogs with hepatic neoplasia.Study designExperimental/descriptive case series.Sample populationSix canine cadavers and 2 clinical dogs.MethodsCadavers in dorsal recumbency underwent laparoscopic assessment of the liver. A 17 gauge MWA probe was inserted to create an ablation zone at the most proximal aspect of the hilus. The distance from the center of each ablation zone to the most proximal aspect of the corresponding hilus was determined. Two dogs with hepatic neoplasia underwent LMWA.ResultsAll lobes of the canine liver were accessible via laparoscopy. The median (interquartile range) distances from the ablation zones to the hilus for the caudate process, left lateral, left middle, quadrate, right lateral, and right middle lobes were 2.2 (1.2–2.6), 2.1 (1–4.4), 1.5 (1.4–3.7), 2, 1, 2.5 (1–4.1) cm, respectively. Histopathologic diagnoses treated by LMWA included metastatic hemangiosarcoma and primary hepatocellular carcinoma. Laparoscopic microwave ablation was technically feasible, and no complications from the procedure resulted.ConclusionLaparoscopic access to the hilus of each liver lobe is possible via a ventrodorsal approach provided reverse Trendelenburg and lateral rotation is used, especially for the right lateral lobe. Laparoscopic microwave ablation is feasible in some dogs with hepatic neoplasia. The indications for and efficacy of LMWA for hepatic neoplasia in dogs requires additional investigation.Clinical significanceLaparoscopic access to all liver lobes and MWA of some neoplastic lesions is feasible in a canine pilot study.
Cerebrovascular reactivity after cessation of menopausal hormone treatment
Barnes, Jill N. , Harvey, Ronée E. , Eisenmann, Nicole A., Miller, Kathleen B. , Johnson, M. C., Kruse, Sarah, Lahr, Brian D. , Miller, Virginia M. , Barnes, J N , Harvey, Ronée E , Joyner, Michael J.

Mayo Clinic

Climacteric | January 21, 2019 | Volume: 22 | Issue: 2 | Pages: 182-189

10.1080/13697137.2018.1538340 | PMID 30661405 Get It

The Development of a Novel Lightweight Transradial Prosthetic: A Proof-of-Concept Study
McBryan, Sarah , Belle, Jeffrey T. La , Malkoc, Aldin

Mayo Clinic

Technology and Innovation | January 14, 2019 | Volume: 20 | Issue: 1-2 | Pages: 47-53

10.21300/20.1-2.2018.47 Get It

Vascular dysfunction—The disregarded partner of Alzheimer's disease
Sweeney, Melanie D. , Montagne, Axel , Nation, Daniel A. , Schneider, Lon S. , Chui, Helena C., Harrington, Michael G. , Pa, Judy , Law, Meng , Wang, Danny J.J. , Jacobs, Russell E. , Doubal, Fergus , Ramirez, Joel , Dichgans, Martin , Love, Seth , Bath, Philip M. , Markus, Hugh S. , Salman, Rustam Al‐Shahi , Kalaria, Rajesh N., Werring, David J. , Moskowitz, Michael A., Katušić, Zvonimir S. , Lazarov, Orly , Rehman, Jalees , Wellington, Cheryl L. , González, Héctor M. , Yuan, Chun , Lockhart, Samuel N. , Hughes, Timothy M. , Chen, Christopher , Sachdev, Perminder S. , O’Brien, John T. , Pantoni, Leonardo , Gustafson, Deborah , Biessels, Geert Jan , Wallin, Anders , Wong, Adrian , Passmore, Peter , Barkof, Frederick, Muller, Majon , Román, Gustavo C. , Hamel, Édith , Seshadri, Sudha , Buchem, Mark A. van , Arvanitakis, Zoe , Drewes, Lester R. , Hachinski, Vladimir , Wardlaw, Joanna M. , Kalaria, Raj N. , Dichgans, Martin , O'Brien, John Tiernan , Wardlaw, Joanna Marguerite , Seshadri, Sudha , Sachdev, Perminder S , Sagare, Abhay P. , Chui, Helena C. , Black, Sandra E. , Nedergaard, Maiken , Benveniste, Helene , Iadecola, Costantino , Allan, Stuart McRae , Quinn, Terence J , Carare, Roxana Octavia , Touyz, Rhian M. , Williams, Steven , Lutz, Sarah E. , Minshall, Richard D. , Davis, Thomas P. , Gonzalez, Hector M , Skoog, Ingmar , Biessels, Geert Jan , Smith, Eric Edward , Mok, Vincent , Breteler, Monique M.B. , Gottesman, Rebecca F. , Schneider, Julie A. , Finch, Caleb E. , Toga, Arthur W. , Zloković, Berislav V. , Al-Shahi Salman, Rustam , Werring, David John , Wang, Danny J J

Mayo Clinic

Alzheimer's & Dementia | January 11, 2019 | Volume: 15 | Issue: 1 | Pages: 158-167

10.1016/j.jalz.2018.07.222 | PMID 30642436 Get It

Abstract Increasing evidence recognizes Alzheimer's disease (AD) as a multifactorial and heterogeneous disease with multiple contributors to its pathophysiology, including vascular dysfunction. The recently updated AD Research Framework put forth by the National Institute on Aging–Alzheimer's Association describes a biomarker‐based pathologic definition of AD focused on amyloid, tau, and neuronal injury. In response to this article, here we first discussed evidence that vascular dysfunction is an important early event in AD pathophysiology. Next, we examined various imaging sequences that could be easily implemented to evaluate different types of vascular dysfunction associated with, and/or contributing to, AD pathophysiology, including changes in blood‐brain barrier integrity and cerebral blood flow. Vascular imaging biomarkers of small vessel disease of the brain, which is responsible for >50% of dementia worldwide, including AD, are already established, well characterized, and easy to recognize. We suggest that these vascular biomarkers should be incorporated into the AD Research Framework to gain a better understanding of AD pathophysiology and aid in treatment efforts.
Calcium sensing receptor in developing human airway smooth muscle
Roesler, A.M., Wicher, Sarah A. , Ravix, Jovanka, Britt, Rodney D. , Manlove, L., Teske, Jacob J. , Cummings, Katelyn, Farver, Carol , MacFarlane, Peter M. , Prakash, Y. S. , Roesler, Anne M, Manlove, Logan, Prakash, Y S , Teske, Jacob J , Thompson, Michael A. , Pabelick, Christina M.

Mayo Clinic

Journal of Cellular Physiology | January 9, 2019 | Volume: 234 | Issue: 8 | Pages: 14187-14197

10.1002/jcp.28115 | PMID 30624783 Get It

Abstract Airway smooth muscle (ASM) regulation of airway structure and contractility is critical in fetal/neonatal physiology in health and disease. Fetal lungs experience higher Ca 2+ environment that may impact extracellular Ca 2+ ([Ca 2+ ] o ) sensing receptor (CaSR). Well‐known in the parathyroid gland, CaSR is also expressed in late embryonic lung mesenchyme. Using cells from 18‐22 week human fetal lungs, we tested the hypothesis that CaSR regulates intracellular Ca 2+ ([Ca 2+ ] i ) in fetal ASM (fASM). Compared with adult ASM, CaSR expression was higher in fASM, while fluorescence Ca 2+ imaging showed that [Ca 2+ ] i was more sensitive to altered [Ca 2+ ] o . The fASM [Ca 2+ ] i responses to histamine were also more sensitive to [Ca 2+ ] o (0–2 mM) compared with an adult, enhanced by calcimimetic R568 but blunted by calcilytic NPS2143. [Ca 2+ ] i was enhanced by endogenous CaSR agonist spermine (again higher sensitivity compared with adult). Inhibition of phospholipase C (U73122; siRNA) or inositol 1,4,5‐triphosphate receptor (Xestospongin C) blunted [Ca 2+ ] o sensitivity and R568 effects. NPS2143 potentiated U73122 effects. Store‐operated Ca 2+ entry was potentiated by R568. Traction force microscopy showed responsiveness of fASM cellular contractility to [Ca 2+ ] o and NPS2143. Separately, fASM proliferation showed sensitivity to [Ca 2+ ] o and NPS2143. These results demonstrate functional CaSR in developing ASM that modulates airway contractility and proliferation.
Efficacy of chest computed tomography prediction of the pathological TNM stage of thymic epithelial tumours†
White, Darin , Hora, Megan J, Jenkins, Sarah M. , Marks, Randolph S., Garces, Yolanda I. , Cassivi, Stephen D. , Roden, Anja C. , White, Darin B

Mayo Clinic

European Journal of Cardio-Thoracic Surgery | January 8, 2019 | Volume: 56 | Issue: 2 | Pages: 285-293

10.1093/ejcts/ezz013 | PMID 30753469 Get It

Abstract OBJECTIVES The aim of this study is to evaluate the efficacy of chest computed tomography (CT) to predict the pathological stage of thymic epithelial tumours (TET) using the recently introduced tumour, node and metastasis (TNM) staging with comparison to the modified Masaoka staging. METHODS Preoperative chest CT examinations in cases of resected TET with sampled lymph nodes (2006–2016) were retrospectively reviewed by 2 thoracic radiologists and radiologically (r) staged using both staging systems. A thoracic pathologist reviewed all cases for the pathological (p) stage. Concordance between r-staging and p-staging was assessed by % agreement and unweighted kappa statistics. Associations between r-stage and p-stage with outcomes were assessed using the Cox proportional hazards regression. RESULTS Sixty patients with TET were included (47 thymomas, 12 thymic carcinomas and 1 atypical carcinoid tumour). Sixteen patients (26.7%) had received neoadjuvant therapy. Fifty-four patients (90.0%) had complete resection. The overall agreement between the r-stage and p-stage was 66.7% (κ = 0.46) for TNM staging and 46.7% (κ = 0.30) for modified Masaoka staging. Agreement between r-assessment and p-assessment of the T, N and M components of the TNM stage was 61.7% (κ = 0.28), 86.7% (κ = 0.48) and 98.3% (κ = 0.88), respectively. CT overstaged 12 patients (20.0%) for TNM staging and 12 patients (20.0%) for modified Masaoka staging and understaged 8 (13.3%) and 20 (33.3%) patients for TNM staging modified Masaoka staging, respectively. The r-TNM staging accuracy was lower for patients with neoadjuvant therapy (50.0% with vs 72.7% without). During a median follow-up of 2.6 years (range 0.1–10.5 years), 12 patients had metastases and/or recurrence; 11 patients died (4 of disease). The r-TNM stage and modified Masaoka stage were associated with overall survival and progression-free survival (P < 0.001). CONCLUSIONS Preoperative chest CT is able to accurately predict p-TNM stage in two-thirds of surgically resected TET, with an agreement between radiological staging and pathological staging superior to the modified Masaoka staging.
Patient-derived xenografts from breast cancer patients before and after neoadjuvant chemotherapy: A prospective study.
Yu, Jia , Gao, Bowen , Moyer, Ann M. , Visscher, Daniel W., Conners, Amy Lynn , Dockter, Travis , Jones, Katie N., McLaughlin, Sarah A. , Copland, John A. , Moreno‐Aspitia, Alvaro , Northfelt, Donald W. , Gray, Richard J. , Weinshilboum, Richard M. , Wang, Liewei , Boughey, Judy C. , Yin, Ping , Sinnwell, Jason P. , Kalari, Krishna R. , Suman, Vera J. , Weinshilboum, Richard M. , Goetz, Matthew P.

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 11130-11130

10.1200/jco.2014.32.15_suppl.11130 Get It

Vismodegib for advanced basal cell carcinoma: Duration of response after vismodegib discontinuation and response to vismodegib retreatment upon disease progression.
Sekulić, Aleksandar , Hainsworth, John D. , Lewis, Karl D. , Oro, Anthony E. , Gesierich, Anja , Bernard, Stephen A. , Dréno, Brigitte , Williams, Sarah, Hou, Jeannie , Fisher, David C. , Mortier, Laurent , Dirix, Luc , Murrell, D F , Hauschild, Axel

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 9081-9081

10.1200/jco.2014.32.15_suppl.9081 Get It

Out-of-pockets costs for patients receiving targeted agents for metastatic renal cell carcinoma.
Kim, Simon P. , Gross, Cary P. , Abouassaly, Robert , Houten, Holly K. Van , Thompson, R. Houston, Smaldone, Marc C., Trinh, Q.D., Sun, Maxine , Han, Leona C., Shah, Nilay D. , Psutka, Sarah P.

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: e15598-e15598

10.1200/jco.2014.32.15_suppl.e15598 Get It